Immunotherapy and Chemotherapy in Unresectable Recurrent Loco-regionally Advanced Nasopharyngeal Carcinoma

Clinical trial NCT04921995 · UNKNOWN

Trial details

NCT number: NCT04921995
Sponsor: Fudan University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Nasopharyngeal Carcinoma Unresectable Nasopharyngeal Carcinoma Chemotherapy Effect Immunotherapy Stereotactic Body Radiation Therapy (SBRT)

Start date: 2019-04-15
Primary completion: 2022-10-30
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.